Drug Shortage Report for APO-TICAGRELOR
| Report ID | 257671 |
| Drug Identification Number | 02482630 |
| Brand name | APO-TICAGRELOR |
| Common or Proper name | Common or Proper name |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TICAGRELOR |
| Strength(s) | 90MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Packaging size |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2025-11-17 |
| Actual start date | |
| Estimated end date | 2028-01-05 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-11-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-11-12 | French | Compare |
| v3 | 2025-11-12 | English | Compare |
| v2 | 2025-11-10 | French | Compare |
| v1 | 2025-11-10 | English | Compare |
Showing 1 to 4 of 4